Signaling Pathway Inhibitors, miRNA, and Nanocarrier-Based Pharmacotherapeutics for the Treatment of Lung Cancer: A Review

Lung cancer is one of the most commonly diagnosed cancers and is responsible for a large number of deaths worldwide. The pathogenic mechanism of lung cancer is complex and multifactorial in origin. Thus, various signaling pathways as targets for therapy are being examined, and many new drugs are in...

Descripción completa

Detalles Bibliográficos
Autores principales: Md, Shadab, Alhakamy, Nabil A., Karim, Shahid, Gabr, Gamal A, Iqubal, Mohammad Kashif, Murshid, Samar S. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708027/
https://www.ncbi.nlm.nih.gov/pubmed/34959401
http://dx.doi.org/10.3390/pharmaceutics13122120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708027/
https://www.ncbi.nlm.nih.gov/pubmed/34959401
http://dx.doi.org/10.3390/pharmaceutics13122120

Ejemplares similares